Xtant Medical (XTNT) - 2024 Q2 - Quarterly Results

Exhibit 99.1 Xtant Medical Reports Second Quarter 2024 Revenue Growth of 48% BELGRADE, Mont., August 8, 2024 — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the second quarter ended June 30, 2024. Second Quarter 2024 Financial Highlights ● Revenue of $29.9 million, up 48%, compared to the prior year quarter ● Gross margin of 62.1%, up 50 basis poin ...